trifluridine ophthalmic solution
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
ophthalmic medication
|
| gptkbp:activeDuring |
gptkb:trifluridine
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availableIn |
prescription medication
|
| gptkbp:brand |
gptkb:Viroptic
|
| gptkbp:clinicalTrials |
herpes simplex keratitis
|
| gptkbp:contains |
gptkb:trifluridine
|
| gptkbp:contraindication |
hypersensitivity to trifluridine
|
| gptkbp:dosageForm |
topical
|
| gptkbp:drugInterdiction |
available_on_FDA_website
|
| gptkbp:formulation |
sterile solution
|
| https://www.w3.org/2000/01/rdf-schema#label |
trifluridine ophthalmic solution
|
| gptkbp:issuedBy |
eye drops
|
| gptkbp:lastProduced |
1998
|
| gptkbp:packaging |
bottle with dropper
|
| gptkbp:shelfLife |
30 days after opening
|
| gptkbp:sideEffect |
blurred vision
eye irritation burning sensation redness of the eye |
| gptkbp:storage |
room temperature
|
| gptkbp:triggerType |
inhibits viral DNA synthesis
|
| gptkbp:usedFor |
treatment of viral keratitis
|